Pediatrics

Children with obesity, asthma, and gastrointestinal disease had longer durations of stays compared with children without comorbidities.

As a rare and serious pediatric disorder, Stargardt disease can cause vision complications in patients.

Inflammation associated with asthma in children could perturb neurodevelopment.

The disorder presents as severe lung disease, with lung transplantation as the only current therapeutic option for long-term survival.

The intervention methods—annual asthma reviews, inhaler technique checks, and asthma management plans—were most effective when performed in the same visit.

The data also shows similar results for children with mothers who have pre-pregnancy body mass index outside of normal range.

The designation follows 2 previous orphan drug designations for pancreatic cancer and soft tissue sarcoma.

There were differences in the variables that influenced vaccination decision making for adults aged 18 to 26 years and for parents making the decision to vaccinate their child

Children with certain atopic conditions, including asthma and common food allergies, were observed to have a higher risk of developing the chronic disorder.

Among this population, about 80% had not previously been diagnosed with asthma and over 30% were not using any asthma medications.

Clesrovimab reduced RSV-associated hospitalizations and RSV-associated lower respiratory infection hospitalizations by more than 84% and 90% in preterm and full-term infants, respectively.

In children aged 12, 18, and 24 months, there was no association between maternal COVID-19 exposure and abnormal scores on a neurodevelopment screening.

Low levels of vitamin D was linked with increased obstructive Apnea-Hypopnea Index scores.

Zaltenibart could be an effective treatment option for C3 glomerulopathy as the most proximal inhibitor of the alternative pathway.

With the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.

There are gonadotoxic risks of chemotherapy, radiation, and surgery that are important to discuss with patients.

The implementation of accountable care organizations (ACOs) also worsened disparities in any emergency department or hospital use for Medicaid-insured children with asthma.

Research funding that aims to understand impacts of systemic racism on pediatric asthma should include plans to undo policies that maintain inequities created by systemic racism.

This review discusses the significance of the FDA-approved drug inotuzumab ozogamicin in pediatric patients with acute lymphocytic leukemia (ALL) and relapsed/refractory (R/R) ALL, and the evolving therapeutic options in R/R ALL.

Patients aged 7 years and older can now be treated for their cataplexy or excessive daytime sleepiness with the extended-release oral formulation.

The increase was observed across multiple subgroups, including those with overweight or obesity and hospitalized patients.

Pharmacists also help patients manage their adverse effects and treat patients to live healthy lives.

Oral immunotherapy is a growing area of research that involves ingesting increasing doses of the allergen to desensitize the patient’s immune system.

Although the findings indicate a potential for predicting asthma or wheezing onset, these trends cannot yet be used for early diagnoses in individual children.